CD274 and cancer: Activated T cells are suppressed by cancer cells via PD-L1, which is eliminated by treatment with Niv and Atz, during secondary and subsequent therapies, thereby restoring the anticancer activity of T cells as well as apoptosis of cancer cells [1,4,12,34]; (Figure 12).